Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Lymphoma 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Nodule 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pancreatitis, Chronic 1Pancreatic Cyst 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Imatinib Mesylate 41Sunitinib 17nilotinib 12regorafenib 10ripretinib 6avapritinib 6Leucovorin 3Ipilimumab 3Gemcitabine 3Dasatinib 3CTLA-4 Antigen 34-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3pexidartinib 2Paclitaxel 2Oxaliplatin 2Midazolam 2Irinotecan 2Fluorouracil 2Floxuridine 2Erlotinib Hydrochloride 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2Biopsy, Fine-Needle 2Bevacizumab 2vatalanib 1umbralisib 1trametinib 1tinostamustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Stromal Tumors × Cytological Techniques × Clear all
NCT01774162 2013-01-23

EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration

University of Alberta

Phase NA Completed
57 enrolled
GastrointestinalLymphoidSarcoma

Lymphoma, Pancreatic Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡